The present paper reviews the results of all publications on in vitro cytokine secretion in patients with schizophrenia, as published by March 2001. The authors supply easy to read tables with respect to the individual cytokines and soluble cytokine receptors investigated, the in vitro methodology used, characterization of the patient samples, and the results on cytokine secretion as stated in these studies. Inconsistent results, e.g., regarding in vitro secretion of IL-2 with 11/18 studies finding decreased secretion, 5/18 finding no change, and 2/18 finding increases, cannot systematically be correlated with any methodological procedures nor any diagnostic subtypes, per se. However, factors such as medication and cigarette smoking are likely to play a role. The authors suggest that more hypothesis-driven research, together with more carefully designed studies, as well as better communication between basic or animal researchers and clinicians might help to answer the question of whether there are meaningful peripheral changes in the immune system related to schizophrenia.
INTRODUCTION
Originally, cytokines were described and named lympho-and monokines in the late 1970s. Interleukin-1 (IL-1), 1 for example, was first named lymphocyte activating factor (Geiger, Gallily, & Gery, 1973) , and human IL-1 was purified in 1980 (Lachman, Page, & Metzgar, 1980) , interleukin-2 (IL-2) was named lymphycyte mitogenic factor (Rutenberg, al-Khalildi, Rosen, & Merler, 1979) , and human IL-2 was purified in 1982 /1983 (Robb, 1982 Degrave, Tavernier, Duerinck, Plaetinck, Devos, & Fiers, 1983) . These cytokines were believed to be humoral mediators exclusively of the immune system. They were named interleukins and interferons ruling inflammatory and infectious processes within the immune system (e.g., Rocklin, Bendtzen, & Greineder, 1980) . However, further structural and functional analyses of these interleukins and interferons and their receptors on the one hand, and analyses of a variety of additional humoral factors and their receptors first described in nonimmune contexts such as growth factors on the other hand, led to the concept of cytokines 1 Abbreviations used: CTLL, cell line, cytotoxic T lymphocytes; DSM, diagnostic and statistical manual of mental disorders, e.g., DSM-IIIR for 3rd edition, revised; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; FCS, fetal calf serum; HeLa, cell line, cervix carcinoma; Hep-2, cell line, hepatocytes; ICD, international classification of diseases, e.g., ICD-10 for 10th edition; IL, interleukin; IFN-α/γ, Interferon-alpha/-gamma; LPS, lipopolysaccharide; NDV, Newcastle disease virus; PBMC, peripheral blood mononuclear cells; PHA, phytohemagglutinin; RDC, research diagnostic criteria; RIA, radioimmunoassay; TNF, tumor necrosis factor; TT, tetanus toxin. 282 0889-1591/01 $35.00
